UNM
68
7
GS
72
-3
DD
38
-2
STI
27
16
TRIP
49
-3
EA
47
-3
AMGN
34
-4
AVGO
42
-3
CCI
41
2
NAVI
30
-2
STZ
45
-3
GWW
64
2
AEE
60
2
HPE
66
-2
KSS
55
-3
ADSK
65
2
DUK
57
2
ACN
56
2
EBAY
59
3
SE
63
6
UNM
68
7
GS
72
-3
DD
38
-2
STI
27
16
TRIP
49
-3
EA
47
-3
AMGN
34
-4
AVGO
42
-3
CCI
41
2
NAVI
30
-2
STZ
45
-3
GWW
64
2
AEE
60
2
HPE
66
-2
KSS
55
-3
ADSK
65
2
DUK
57
2
ACN
56
2
EBAY
59
3
SE
63
6
Financhill
Back

Phathom Pharmaceuticals, Inc. Vs. Lixte Biotechnology Holdings, Inc. Industry Stock Comparison

Sell
37

PHAT
Phathom Pharmaceuticals, Inc.

Last Price:
$16.91
Seasonality Move:
-12.11%
Sell
30

LIXT
Lixte Biotechnology Holdings, Inc.

Last Price:
$3.94
Seasonality Move:
0.31%
Sell
37
Phathom Pharmaceuticals, Inc. (PHAT) is a Sell

Is Phathom Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals, Inc. [PHAT] share price is $17.22. The Score for PHAT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • PHAT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Lixte Biotechnology Holdings, Inc. (LIXT) is a Sell

Is Lixte Biotechnology Holdings, Inc. a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings, Inc. [LIXT] share price is $3.92. The Score for LIXT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals, Inc.'s stock price today?

  • The Phathom Pharmaceuticals, Inc. share price today is $17.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings, Inc.'s stock price today?

  • The Lixte Biotechnology Holdings, Inc. share price today is $3.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing slight selling pressure.

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.82 Buy
Relative Strength Index (14 RSI): 65.64 Buy
Chaikin Money Flow: -232950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.36 - 16.72) Buy
Bollinger Bands (100): (11.24 - 15.04) Buy

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 42.66 Sell
Chaikin Money Flow: -22293 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.01 - 4.29) Sell
Bollinger Bands (100): (3.89 - 4.99) Sell

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.09 Buy
20-day SMA: 15.65 Buy
50-day SMA: 14.71 Buy
200-day SMA: 9.78 Buy
8-day EMA: 14.99 Buy
20-day EMA: 9.48 Buy
50-day EMA: 4.69 Buy
200-day EMA: 1.31 Buy

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.06 Sell
20-day SMA: 4.12 Sell
50-day SMA: 4.24 Sell
200-day SMA: 3.13 Buy
8-day EMA: 4.06 Sell
20-day EMA: 4.12 Sell
50-day EMA: 4.23 Sell
200-day EMA: 3.55 Buy

Phathom Pharmaceuticals, Inc. Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.24 per share, and a decrease next year of $0.00 per share.

Lixte Biotechnology Holdings, Inc. Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Phathom Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lixte Biotechnology Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):